BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 33076877)

  • 1. Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: a single-center retrospective study.
    Wang J; Wang Y; Li X; Huang Y; Sun X; Wang Q; Zhang M
    BMC Pulm Med; 2020 Oct; 20(1):272. PubMed ID: 33076877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum uric Acid as a prognostic predictor in pulmonary arterial hypertension with connective tissue disease.
    Njaman W; Iesaki T; Iwama Y; Takasaki Y; Daida H
    Int Heart J; 2007 Jul; 48(4):523-32. PubMed ID: 17827824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic variables and clinical features correlated with serum uric acid in patients with pulmonary arterial hypertension.
    Jiang X; Han ZY; Wang Y; Xu XQ; Ma CR; Wu Y; Pan L; Jing ZC
    Chin Med J (Engl); 2008 Dec; 121(24):2497-503. PubMed ID: 19187585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
    Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
    Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective cohort study of pulmonary arterial hypertension associated with connective tissue disease effect on patients' prognosis.
    Huang J; An Q; Shi H; Li C; Zhang W; Wang L
    Clin Rheumatol; 2023 Nov; 42(11):3131-3142. PubMed ID: 37382842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and prognostic factors in connective tissue disease-associated pulmonary arterial hypertension patients complicated with right heart failure.
    Deng X; Jiang N; Huang C; Zhou S; Peng L; Zhang L; Liu J; Wang L; Zhou J; Wang Q; Weng L; Peng J; Zhao J; Li M; Zeng X
    Int J Rheum Dis; 2023 May; 26(5):862-869. PubMed ID: 36892249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors of pulmonary hypertension associated with connective tissue disease: pulmonary artery size measured by chest CT.
    Li X; Zhang C; Sun X; Yang X; Zhang M; Wang Q; Zhu Y
    Rheumatology (Oxford); 2020 Nov; 59(11):3221-3228. PubMed ID: 32221604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry.
    Chen X; Quan R; Qian Y; Yang Z; Yu Z; Zhang C; Yang Y; Zhang G; Shen J; Wang Q; Gu Q; Xiong C; Jing X; Han H; He J
    Rheumatology (Oxford); 2023 Nov; 62(11):3555-3564. PubMed ID: 36912696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
    Cansu DÜ; Korkmaz C
    Clin Rheumatol; 2023 Oct; 42(10):2601-2610. PubMed ID: 36396789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension.
    Langleben D; Orfanos SE; Giovinazzo M; Hirsch A; Baron M; Senécal JL; Armaganidis A; Catravas JD
    Arthritis Rheum; 2008 Apr; 58(4):1156-64. PubMed ID: 18383374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and pulmonary uric acid in pulmonary arterial hypertension.
    Savale L; Akagi S; Tu L; Cumont A; Thuillet R; Phan C; Le Vely B; Berrebeh N; Huertas A; Jaïs X; Cottin V; Chaouat A; Tromeur C; Boucly A; Jutant EM; Mercier O; Fadel E; Montani D; Sitbon O; Humbert M; Tamura Y; Guignabert C
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 33446602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis.
    Kuwana M; Blair C; Takahashi T; Langley J; Coghlan JG
    Ann Rheum Dis; 2020 May; 79(5):626-634. PubMed ID: 32161055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Impact of Serum Uric Acid on Disease Severity and 5-Year Mortality in Patients With Idiopathic Pulmonary Artery Hypertension.
    Yan L; Huang Z; Zhao Z; Zhao Q; Tang Y; Zhang Y; Li X; Duan A; Luo Q; Liu Z
    Front Med (Lausanne); 2022; 9():805415. PubMed ID: 35155496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.
    Thoreau B; Mouthon L
    Autoimmun Rev; 2024 Apr; 23(4):103506. PubMed ID: 38135175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nailfold videocapillaroscopic changes in patients with pulmonary arterial hypertension associated with connective tissue diseases.
    Arvanitaki A; Giannakoulas G; Triantafyllidou E; Pagkopoulou E; Boutou A; Garyfallos A; Karvounis H; Dimitroulas T
    Rheumatol Int; 2021 Jul; 41(7):1289-1298. PubMed ID: 33978819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for connective tissue disease in pulmonary arterial hypertension.
    Pagán RJ; Lee AS; Austin CO; Burger CD
    South Med J; 2014 Oct; 107(10):666-9. PubMed ID: 25279875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis.
    Sargent T; Tsang Y; Panjabi S; Funtanilla V; Germack HD; Gauthier-Loiselle M; Manceur AM; Cloutier M; Lefebvre P
    Adv Ther; 2023 Nov; 40(11):5037-5054. PubMed ID: 37728697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise pathophysiology differs between connective tissue diseases-associated pulmonary arterial hypertension and idiopathic pulmonary arterial hypertension.
    Zhang Y; Jin Q; Zhao Z; Zhao Q; Yu X; Yan L; Li X; An C; Ma X; Xiong C; Luo Q; Liu Z
    Clin Exp Rheumatol; 2021; 39(5):1063-1070. PubMed ID: 33200733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Long-term Outcomes in Patients With Connective Tissue Disease Associated With Pulmonary Arterial Hypertension.
    Nakayama K; Nakajima Y; Tanaka R; Hirata KI; Emoto N
    J Clin Rheumatol; 2021 Dec; 27(8):e371-e377. PubMed ID: 32511146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive therapy in patients with connective tissue disease-associated pulmonary arterial hypertension: A systematic review.
    Ding Y; Qian J; Zhang S; Xu D; Leng X; Zhao J; Wang Q; Zhang W; Tian X; Li M; Zeng X
    Int J Rheum Dis; 2022 Sep; 25(9):982-990. PubMed ID: 35699128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.